Prelude Capital Management, LLC Opti Nose, Inc. Transaction History

Prelude Capital Management, LLC

$1.85 Billion
Q1 2024

A detailed history of Prelude Capital Management, LLC transactions in Opti Nose, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 360,000 shares of OPTN stock, worth $374,400. This represents 0.03% of its overall portfolio holdings.

Number of Shares

360,000

Previous 270,000 33.33%

Holding current value

$374,400

Previous $348,000 50.86%

% of portfolio

0.03%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.17 - $1.94 $105,300 - $174,600	90,000 Added 33.33%	360,000 $525,000
Q4 2023 Feb 14, 2024	BUY	$1.02 - $1.47 $91,800 - $132,300	90,000 Added 50.0%	270,000 $348,000
Q3 2023 Nov 14, 2023	BUY	$0.93 - $1.38 $27,900 - $41,400	30,000 Added 20.0%	180,000 $221,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.05 $7,710 - $14,239	-6,946 Reduced 4.43%	150,000 $184,000
Q1 2023 May 15, 2023	BUY	$1.63 - $2.02 $14,327 - $17,755	8,790 Added 5.93%	156,946 $302,000

Q4 2022 Feb 14, 2023	BUY	$1.68 - $3.7 $262 - $577	156 Added 0.11%	148,156 $274,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $4.01 $6,860 - $8,020	-2,000 Reduced 1.33%	148,000 $542,000
Q2 2022 Aug 15, 2022	BUY	$1.76 - $3.82 $44,000 - $95,500	25,000 Added 20.0%	150,000 $549,000
Q1 2022 May 16, 2022	BUY	$1.77 - $2.93 $93,810 - $155,290	53,000 Added 73.61%	125,000 $309,000
Q3 2021 Nov 15, 2021	BUY	$2.35 - $3.16 $84,600 - $113,760	36,000 Added 100.0%	72,000 $216,000
Q2 2021 Aug 16, 2021	BUY	$2.91 - $3.83 $34,920 - $45,960	12,000 Added 50.0%	36,000 $112,000
Q1 2021 May 17, 2021	BUY	$3.47 - $4.75 $83,280 - $114,000	24,000 New	24,000 $89,000
Q1 2020 May 15, 2020	SELL	$3.49 - $9.2 $1,047 - $2,760	-300 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.27 - $11.41 $1,880 - $3,423	300 New	300 $3,000
Q3 2018 Nov 14, 2018	SELL	$12.43 - $29.76 $2.12 Million - $5.08 Million	-170,724 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$18.75 - $28.46 $160,181 - $243,133	-8,543 Reduced 4.77%	170,724 $4.78 Million
Q1 2018 May 15, 2018	BUY	$15.91 - $20.82 $348,126 - $455,562	21,881 Added 13.9%	179,267 $3.59 Million
Q4 2017 Feb 14, 2018	BUY	$15.2 - $20.76 $2.39 Million - $3.27 Million	157,386	157,386 $2.98 Million

Others Institutions Holding OPTN

# of Institutions

Shares Held

59.6M

Call Options Held

Put Options Held

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $86.6M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Opti Nose, Inc. Transaction History